111 (YI) Cash from Investing Activities Growth (1y) (2018 - 2025)
111 (YI) Cash from Investing Activities Growth (1y) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Akso Health |
2,315,158.81 Bn |
2,315,158.63 Bn |
- |
- |
| 2 |
Mckesson |
92.76 Bn |
89.18 Bn |
4.04 Bn |
289.73% |
| 3 |
Cencora |
52.82 Bn |
50.83 Bn |
3.59 Bn |
-19.55% |
| 4 |
Cardinal Health |
52.17 Bn |
48.39 Bn |
2.50 Bn |
93.75% |
| 5 |
Henry Schein |
9.19 Bn |
9.71 Bn |
1.07 Bn |
36.36% |
| 6 |
Accendra Health |
246.88 Mn |
-90.00 Mn |
312.39 Mn |
211.88% |
| 7 |
Edap Tms |
161.92 Mn |
146.92 Mn |
8.15 Mn |
42.18% |
| 8 |
111 |
107.47 Mn |
25.61 Mn |
23.58 Mn |
-161.42% |
| 9 |
Cosmos Health |
9.42 Mn |
7.26 Mn |
1.38 Mn |
-9,929.18% |
| 10 |
Cellyan Biotechnology |
5.69 |
-2.48 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
-161.42% |
| Sep 30, 2025 |
-159.28% |
| Jun 30, 2025 |
99.72% |
| Mar 31, 2025 |
-103.64% |
| Dec 31, 2024 |
-38.02% |
| Sep 30, 2024 |
903.25% |
| Jun 30, 2024 |
-156.85% |
| Mar 31, 2024 |
153.19% |
| Dec 31, 2023 |
149.17% |
| Sep 30, 2023 |
-94.99% |
| Jun 30, 2023 |
347.19% |
| Mar 31, 2023 |
-314.75% |
| Dec 31, 2022 |
-158.40% |
| Sep 30, 2022 |
137.53% |
| Jun 30, 2022 |
-262.14% |
| Mar 31, 2022 |
-72.37% |
| Dec 31, 2021 |
188.51% |
| Sep 30, 2021 |
-152.35% |
| Jun 30, 2021 |
1,263.04% |
| Mar 31, 2021 |
2,315.62% |
